CHRS
Coherus BioSciences Inc
1.00$
-1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -203.8% | – | -190.3% | – | – | – | – | – | – | |
| – | +18.2% | +41.8% | -21.2% | +30.5% | -33.3% | +1.3% | -2.9% | -4.9% | -7.2% | -1.7% | -2.2% | – | |
| – | +8.5% | -32.2% | -1.2% | -5.0% | -7.0% | -15.9% | +0.9% | -37.5% | +218.5% | -77.9% | +108.3% | – | |
| – | – | -278.6% | – | -182.9% | – | -80.1% | -317.8% | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -30.4% | +476.0% | -86.4% | -98.4% | -222.1% | +3,126.2% | – | -114.5% | -95.8% | – | +96.7% | – | |
| – | – | -122.8% | +129.7% | -99.4% | +0.0% | +2,540.0% | – | – | +8,700.0% | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | -96.7% | +142.3% | -21,286.6% | -99.9% | – | -214.3% | +106,537.9% | – | +403,950.0% | +563.2% | +0.3% | – | |
| – | +201.7% | +607.3% | -164.1% | – | – | -254.0% | – | -184.4% | – | – | -122.6% | – | |
| – | – | – | – | -203.8% | – | -190.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.